Description of studies using nonvisual method for iPET interpretation
| References . | DLBCL pts (n) . | Median age . | Type of study . | Treatment . | Nb of cycles of chemotherapy before iTEP . | iTEP analysis method . | iTEP-driven . |
|---|---|---|---|---|---|---|---|
| Lin et al20 | 92 | 54 | Multicentric prospective | CHOP or ACVBP ± R | 2 | Visual and SUV-based centrally | No |
| Itti et al21 | 80 | 53 | Multicentric prospective | CHOP or ACVBP ± R | 4 | Visual and SUV-based centrally | No |
| Casasnovas et al13,25 | 113 | 46, all patients <60 y | Multicentric prospective | R-CHOP or R-ACVBP | 2 and 4 | Visual centrally reviewed in real-time IHP and ΔSUVmax | Yes, according to visual result but not to D5Smax or ΔSUV |
| Lanic et al33 | 57 GC: 30; non-GC: 27 | 65 | Monocentric retrospective | R-CHOP or R-CHOP-like | 3 or 4 | Visual and ΔSUV (70%) local | No |
| Safar et al22 | 85 (subgroup analysis) | 59 | Multicentric prospective | R-CHOP or R-ACVBP | 2 | ΔSUV central | No |
| Pregno et al50 | 88 | 55 | Multicentric retrospective | R-CHOP-2/14 | After 2 (n = 58); after 3 (n = 9); after 4 (n = 21) | Deauville scale and ΔSUV (n = 46) central review | No |
| Nols et al51 | 73 | 60 | Bicentric retrospective | R-CHOP or R-ACVBP | After 3 cycles (n = 13) or 4 (n = 60) | Deauville and ΔSUV local | No |
| Lee et al7 | 50 DLBCL out of 61 | 57 | Monocentric prospective | R-CHOP | 1 | Semiquantitative based on SUVmax local | No |
| Mylan et al6 | 112 | 62 | Multicentric prospective | R-CHOP | 1 | IHP and Deauville scale | No |
| Mamot et al23 | 138 GC: 34%; non-GC: 66% | 58.4 | Multicentric retrospective for Deauville and ΔSUV | R-CHOP-14 | 2 | Central for Deauville and ΔSUV | No |
| References . | DLBCL pts (n) . | Median age . | Type of study . | Treatment . | Nb of cycles of chemotherapy before iTEP . | iTEP analysis method . | iTEP-driven . |
|---|---|---|---|---|---|---|---|
| Lin et al20 | 92 | 54 | Multicentric prospective | CHOP or ACVBP ± R | 2 | Visual and SUV-based centrally | No |
| Itti et al21 | 80 | 53 | Multicentric prospective | CHOP or ACVBP ± R | 4 | Visual and SUV-based centrally | No |
| Casasnovas et al13,25 | 113 | 46, all patients <60 y | Multicentric prospective | R-CHOP or R-ACVBP | 2 and 4 | Visual centrally reviewed in real-time IHP and ΔSUVmax | Yes, according to visual result but not to D5Smax or ΔSUV |
| Lanic et al33 | 57 GC: 30; non-GC: 27 | 65 | Monocentric retrospective | R-CHOP or R-CHOP-like | 3 or 4 | Visual and ΔSUV (70%) local | No |
| Safar et al22 | 85 (subgroup analysis) | 59 | Multicentric prospective | R-CHOP or R-ACVBP | 2 | ΔSUV central | No |
| Pregno et al50 | 88 | 55 | Multicentric retrospective | R-CHOP-2/14 | After 2 (n = 58); after 3 (n = 9); after 4 (n = 21) | Deauville scale and ΔSUV (n = 46) central review | No |
| Nols et al51 | 73 | 60 | Bicentric retrospective | R-CHOP or R-ACVBP | After 3 cycles (n = 13) or 4 (n = 60) | Deauville and ΔSUV local | No |
| Lee et al7 | 50 DLBCL out of 61 | 57 | Monocentric prospective | R-CHOP | 1 | Semiquantitative based on SUVmax local | No |
| Mylan et al6 | 112 | 62 | Multicentric prospective | R-CHOP | 1 | IHP and Deauville scale | No |
| Mamot et al23 | 138 GC: 34%; non-GC: 66% | 58.4 | Multicentric retrospective for Deauville and ΔSUV | R-CHOP-14 | 2 | Central for Deauville and ΔSUV | No |